Kioxia Holdings, the memory chipmaker spun out of Toshiba in 2018, wants to raise $3.3B in Japan's biggest IPO of 2020 that could value the company at $19.79B
Context & Ripple Effects
Kioxia was carved out of Toshiba in 2018, when a Bain-led group paid $18B for the memory business; this $3.3B offering at a possible [[a:|Kioxia]] $19.79B valuation was framed as Japan's biggest IPO of 2020 and the consortium's first real path to liquidity. The listing attempt was short-lived: within a month Kioxia called off the $16B IPO, citing Huawei export restrictions hitting its NAND business.
The arc matters because the company eventually returned to market four years later at a fraction of this ambition — the December 2024 Tokyo debut priced near $9.70 and valued Kioxia at roughly $5.2B, about a quarter of the 2020 target — before rallying 500%+ in 2025 on AI-driven memory demand.
First-order effects
- The Bain consortium and Toshiba would gain a listed vehicle to mark and partially exit an $18B leveraged buyout, while Tokyo Exchanges gets its largest 2020 listing.
- Kioxia itself would raise $3.3B for capex in a capital-intensive NAND market, at a valuation that assumes memory pricing holds.
Second-order effects
- The deal's dependence on Huawei-exposed NAND demand is its own biggest risk — export restrictions on Huawei are what ultimately killed this IPO a month later.
- A successful mega-IPO would have set the 2020 pricing benchmark for Japanese chip listings; its collapse pushed Kioxia's eventual 2024 float down to a ~$5.2B valuation, resetting expectations for the Bain group's recovery.
Third-order effects
- The gap between the $19.79B sought in 2020 and the ~$5.2B achieved in 2024 — followed by a 500%+ 2025 rally — shows how memory-chip valuations swing on the AI data-center demand cycle rather than on fundamentals alone.
- For Japan's capital markets, the episode fits a pattern the corpus flags elsewhere: a thin domestic pipeline of chip and AI listings, which Dealogic ties to Japan's weak IPO market and its scramble to build domestic AI capacity.
The trend: Kioxia's aborted 2020 mega-IPO and discounted 2024 relisting trace how memory-maker valuations have become hostage to AI demand cycles and US-China export policy, with Tokyo's chip-listing pipeline thin enough that each deal moves the market.